BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9531473)

  • 21. Theoretical investigation of astacin proteolysis.
    Chen SL; Li ZS; Fang WH
    J Inorg Biochem; 2012 Jun; 111():70-9. PubMed ID: 22484502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and structural insights into astacin metallopeptidases.
    Gomis-Rüth FX; Trillo-Muyo S; Stöcker W
    Biol Chem; 2012 Oct; 393(10):1027-41. PubMed ID: 23092796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphinic peptides as zinc metalloproteinase inhibitors.
    Dive V; Georgiadis D; Matziari M; Makaritis A; Beau F; Cuniasse P; Yiotakis A
    Cell Mol Life Sci; 2004 Aug; 61(16):2010-9. PubMed ID: 15316651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
    Gall AL; Ruff M; Kannan R; Cuniasse P; Yiotakis A; Dive V; Rio MC; Basset P; Moras D
    J Mol Biol; 2001 Mar; 307(2):577-86. PubMed ID: 11254383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases.
    Mac Sweeney A; Gil-Parrado S; Vinzenz D; Bernardi A; Hein A; Bodendorf U; Erbel P; Logel C; Gerhartz B
    J Mol Biol; 2008 Dec; 384(1):228-39. PubMed ID: 18824173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction of recombinant subdomains of the procollagen C-proteinase with procollagen I provides a quantitative explanation for functional differences between the two splice variants, mammalian tolloid and bone morphogenetic protein 1.
    Hintze V; Höwel M; Wermter C; Grosse Berkhoff E; Becker-Pauly C; Beermann B; Yiallouros I; Stöcker W
    Biochemistry; 2006 May; 45(21):6741-8. PubMed ID: 16716085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meprins, membrane-bound and secreted astacin metalloproteinases.
    Sterchi EE; Stöcker W; Bond JS
    Mol Aspects Med; 2008 Oct; 29(5):309-28. PubMed ID: 18783725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization and Structure-Activity Relationships of Phosphinic Pseudotripeptide Inhibitors of Aminopeptidases That Generate Antigenic Peptides.
    Kokkala P; Mpakali A; Mauvais FX; Papakyriakou A; Daskalaki I; Petropoulou I; Kavvalou S; Papathanasopoulou M; Agrotis S; Fonsou TM; van Endert P; Stratikos E; Georgiadis D
    J Med Chem; 2016 Oct; 59(19):9107-9123. PubMed ID: 27606717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic organization of the zinc-endopeptidase astacin.
    Geier G; Jacob E; Stöcker W; Zwilling R
    Arch Biochem Biophys; 1997 Jan; 337(2):300-7. PubMed ID: 9016826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic studies on the inhibition of stromelysin by a peptide phosphonamidate.
    Izquierdo-Martin M; Stein RL
    Bioorg Med Chem; 1993 Jul; 1(1):19-26. PubMed ID: 8081834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.
    Tan K; Jäger C; Schlenzig D; Schilling S; Buchholz M; Ramsbeck D
    ChemMedChem; 2018 Aug; 13(16):1619-1624. PubMed ID: 29927060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active methylene phosphinic peptides: a new diversification approach.
    Matziari M; Nasopoulou M; Yiotakis A
    Org Lett; 2006 May; 8(11):2317-9. PubMed ID: 16706515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of slow-binding inhibition of human leukocyte elastase by trifluoromethyl ketones.
    Stein RL; Strimpler AM; Edwards PD; Lewis JJ; Mauger RC; Schwartz JA; Stein MM; Trainor DA; Wildonger RA; Zottola MA
    Biochemistry; 1987 May; 26(10):2682-9. PubMed ID: 3649251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphinic peptides as potent inhibitors of zinc-metalloproteases.
    Georgiadis D; Dive V
    Top Curr Chem; 2015; 360():1-38. PubMed ID: 25370521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin.
    Gomis-Rüth FX; Kress LF; Kellermann J; Mayr I; Lee X; Huber R; Bode W
    J Mol Biol; 1994 Jun; 239(4):513-44. PubMed ID: 8006965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analogue inhibitors of thermolysin.
    Bartlett PA; Marlowe CK
    Biochemistry; 1987 Dec; 26(26):8553-61. PubMed ID: 3442676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorus amino acid analogues as inhibitors of leucine aminopeptidase.
    Giannousis PP; Bartlett PA
    J Med Chem; 1987 Sep; 30(9):1603-9. PubMed ID: 3625708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. News from an ancient world: two novel astacin metalloproteases from the horseshoe crab.
    Becker-Pauly C; Bruns BC; Damm O; Schütte A; Hammouti K; Burmester T; Stöcker W
    J Mol Biol; 2009 Jan; 385(1):236-48. PubMed ID: 18996129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors.
    Buchardt J; Schiødt CB; Krog-Jensen C; Delaissé JM; Foged NT; Meldal M
    J Comb Chem; 2000; 2(6):624-38. PubMed ID: 11138549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.